![](/img/cover-not-exists.png)
Analysis of Two Commercially Available Bortezomib Products: Differences in Assay of Active Agent and Impurity Profile
Stephen R. Byrn, Patrick A. Tishmack, Mark J. Milton, Helgi van de VeldeVolume:
12
Language:
english
Pages:
7
DOI:
10.1208/s12249-010-9554-1
Date:
June, 2011
File:
PDF, 189 KB
english, 2011